The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication

Biochemical Journal

Volumn 381, Issue 2, 2004, Pages 437-446

  Andrade, Anderson A ^a,b   Silva, Patrícia N G ^a,b   Pereira, Anna C T C ^a,b   De Sousa, Lirlândia P ^a,b   Ferreira, Paulo C P ^b   Gazzinelli, Ricardo T ^a,c   Kroon, Erna G ^b   Ropert, Catherine ^c   Bonjardim, Cláudio A ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Campus Pampulha   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

egr 1; Extracellular signal regulated kinase 1 2 (ERK1 2); MAPK ERK kinase (MEK); Signal transduction; Vaccinia virus (VV); VV growth factor (VGF)

Indexed keywords

BIOSYNTHESIS; DNA; ENZYMES; POLYMERIZATION; VIRUSES;

GROWTH FACTORS; VIRUS MULTIPLICATION;

BIOCHEMISTRY;

ACTIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE; PROTEIN TYROSINE KINASE; RIBOSOME DNA; THYMIDINE KINASE; TRANSCRIPTION FACTOR ELK 1; VIRUS DNA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DNA REPLICATION; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; MICROTUBULE ASSEMBLY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; VACCINIA VIRUS; VIROGENESIS; VIRUS GENE;

3T3 CELLS; ACTINS; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; DNA REPLICATION; DNA, VIRAL; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; ENZYME ACTIVATION; ETS-DOMAIN PROTEIN ELK-1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, VIRAL; GENES, IMMEDIATE-EARLY; IMMEDIATE-EARLY PROTEINS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDES; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RIBOSOMAL PROTEIN S6 KINASES; TRANSCRIPTION FACTORS; VACCINIA VIRUS; VERO CELLS; VIRUS REPLICATION;

ANIMALIA; CERVUS ELAPHUS; DNA VIRUSES; SOUSA; VACCINIA VIRUS;

EID: 3242746584     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20031375     Document Type: Article

References (51)

1. Moss, B. (1996) Poxviridae viruses and their replication. In Fields Virology, vol. 2 (Fields, B. N., Knipe, D. M. and Howley, P. M., eds.), 3rd edn, pp. 2637-2672, Lippincott-Raven Publishers, NY
2. Symons, J. A., Alcami, A. and Smith, G. L. (1995) Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell (Cambridge, Mass.) 81, 551-560
3. Upton, C., Mossman, K. and McFadden, G. (1992) Encoding of a homolog of the IFM-γ receptor by myxoma virus. Science 258, 1369-1372
4. Bowie, A., Kiss-Toth, E., Symons, J. A., Smith, G. L., Dower, S. K. and O'Neili, L. A. (2000) A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 97, 10162-10167
5. Alcami, A. (2003) Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3, 36-50
6. Twardzik, D. R., Brown, J. P., Ranchalis, J. E., Todaro, G. J. and Moss, B. (1985) Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors. Proc. Natl. Acad. Sci. U.S.A. 82, 5300-5304
7. Brown, J. P., Twardzik, D. R., Marquardt, H. and Todaro, G. J. (1985) Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor. Nature (London) 313, 491-492
8. Buller, R. M., Chakrabarti, S., Moss, B. and Fredrickson, T. (1988) Cell proliferative response to vaccinia virus is mediated by VGF. Virology 164, 182-192
9. Tzahar, E., Moyer, J. D., Waterman, H., Barbacci, E. G., Bao, J., Levkowitz, G., Shelly, M., Strano, S., Pinkas-Kramarski, R., Pierce, J. H. et al. (1998) Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network. EMBO J. 17, 5948-5963
10. Sears, R. C. and Nevins, J. R. (2002) Signaling networks that link cell proliferation and cell fate. J. Biol. Chem. 277, 11617-11620
11. Lee, S., Tarn, C., Wang, W. H., Chen, S., Hullinger, R. L. and Andrisani, O. M. (2002) Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines. J. Biol. Chem. 277, 8730-8740
12. Perkins, D., Pereira, E. F., Gober, M., Yarowsky, P. J. and Aurelian, L. (2002) The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bad-1. J. Virol. 76, 1435-1449
13. Yang, X. and Gabuzda, D. (1998) Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif protein. J. Biol. Chem. 273, 29879-29887
14. Pleschka, S., Wolff, T., Ehrhardt, C., Hobom, G., Planz, O., Rapp, U. R. and Ludwig, S. (2001) Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat. Cell Biol. 3, 301-305
15. Opavsky, M. A., Martino, T., Rabinovitch, M., Penninger, J., Richardson, C., Petric, M., Trinidad, C., Butcher, L., Chan, J. and Liu, P. P. (2002) Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J. Clin. Invest. 109, 1561-1569
16. de Magalhães, J. C., Andrade, A. A., Silva, P. N., Sousa, L. P., Ropert, C., Ferreira, P. C., Kroon, E. G., Gazzinelli, R. T. and Bonjardim, C. A. (2001) A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication. J. Biol. Chem. 276, 38353-38360
17. Perkins, D., Pereira, E. F. and Aurelian, L. (2003) The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway. J. Virol. 77, 1292-1305
18. Da Fonseca, F. G., Trindade, G. S., Silva, R. L., Bonjardim, C. A., Ferreira, P. C. and Kroon, E. G. (2002) Characterization of a vaccinia-like virus isolated in a Brazilian forest. J. Gen. Virol. 83, 223-228
19. Buller, R. M., Chakrabarti, S., Cooper, J. A., Twardzik, D. R. and Moss, B. (1988) Deletion of the vaccinia virus growth factor gene reduces virus virulence. J. Virol. 62, 866-874
20. Joklik, W. R. (1962) The purification of four strains of poxvirus. Virology 18, 9-18
21. Locker, J. K., Kuehn, A., Schleich, S., Rutter, G., Hohenberg, H., Wepf, R. and Griffiths, G. (2000) Entry of the two infectious forms of vaccinia virus at the plasma membrane is signaling-dependent for the IMV but not the EEV. Mol. Biol. Cell 11, 2497-2511
22. Franco, G. R., de Carvalho, A. F., Kroon, E. G., Lovagie, S., Werenne, J., Golgher, R. R., Ferreira, P. C. and Bonjardim, C. A. (1999) Biological activities of a human amniotic membrane interferon. Placenta 20, 189-196
23. Rempel, R. E., Anderson, M. K., Evans, E. and Traktman, P. (1990) Temperature-sensitive vaccinia virus mutants identify a gene with an essential role in viral replication. J. Virol. 64, 574-583
24. Marques, J. T., Trindade, G. D., Da Fonseca, F. G., Dos Santos, J. R., Bonjardim, C. A., Ferreira, P. C. and Kroon, E. G. (2001) Characterization of ATI, TK and IFN-α/αR genes in the genome of the BeAn 58058 virus, a naturally attenuated wild orthopoxvirus. Virus Genes 23, 291-301
25. Johnston, J. B., Barrett, J. W., Chang, W., Chung, C. S., Zeng, W., Masters, J., Mann, M., Wang, F., Cao, J. and McFadden, G. (2003) Role of the serine-threonine kinase PAK-1 in myxoma virus replication. J. Virol. 77, 5877-5888
26. Frischknecht, F., Moreau, V., Rottger, S., Gonfloni, S., Reckmann, I., Superti-Furga, G. and Way, M. (1999) Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature (London) 401, 926-929
27. Cooper, J. A. (1987) Effects of cytochalasin and phalloidin on actin. J. Cell Biol. 105, 1473-1478
28. Storrie, B., White, J., Rottger, S., Stelzer, E. H., Suganuma, T. and Nilsson, T. (1998) Recycling of Golgi-resident glycosyltransferases through the ER reveals a novel pathway and provides an explanation for nocodazole-induced Golgi scattering. J. Cell Biol. 143, 1505-1521
29. Baldick, Jr, C. J. and Moss, B. (1993) Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate-stage genes. J. Virol. 67, 3515-3527
30. Hazzalin, C. A. and Mahadevan, L. C. (2002) MAPK-regulated transcription: a continuously variable gene switch? Nat. Rev. Mol. Cell Biol. 3, 30-40
31. Greber, U. F. (2002) Signalling in viral entry. Cell. Mol. Life Sci. 59, 608-626
32. Jacque, J. M., Mann, A., Enslen, H., Sharova, N., Brichacek, B., Davis, R. J. and Stevenson, M. (1998) Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. EMBO J. 17, 2607-2618
33. Barber, S. A., Bruett, L., Douglass, B. R., Herbst, D. S., Zink, M. C. and Clements, J. E. (2002) Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology. J. Virol. 76, 817-828
34. Alessi, D. R., Gomez, N., Moorhead, G., Lewis, T., Keyse, S. M. and Cohen, P. (1995) Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Curr. Biol. 5, 283-295
35. Sun, H., Charles, C. H., Lau, L. F. and Tonks, N. K. (1993) MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell (Cambridge, Mass.) 75, 487-493
36. Smith, J. A., Poteet-Smith, C. E., Malarkey, K. and Sturgill, T. W. (1999) Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J. Biol. Chem. 274, 2893-2898
37. Lazar, D. F., Wiese, R. J., Brady, M. J., Mastick, C. C., Waters, S. B., Yamauchi, K., Pessin, J. E., Cuatrecasas, P. and Saltiel, A. R. (1995) Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. J. Biol. Chem. 270, 20801-20807
38. Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A. and Greenberg, M. E. (1999) Cell survival promoted by the Ras-MAPK signalling pathway by transcription-dependent and -independent mechanisms. Science 286, 1358-1362
39. Zha, J., Harada, H., Yang, E., Jockel, J. and Korsmeyer, S. J. (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell (Cambridge, Mass.) 87, 619-628
40. Scheid, M. P., Schubert, K. M. and Duronio, V. (1999) Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase. J. Biol. Chem. 274, 31108-31113
41. Kibler, K. V., Shors, T., Perkins, K. B., Zeman, C. C., Banaszak, M. P., Biesterfeldt, J., Langland, J. O. and Jacobs, B. L. (1997) Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J. Virol. 71, 1992-2003
42. Garcia, M. A., Guerra, S., Gil, J., Jimenez, V. and Esteban, M. (2002) Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L. Oncogene 21, 8379-8387
43. Sukhatme, V. P., Cao, X. M., Chang, L. C., Tsai-Morris, C. H., Stamenkovich, D., Ferreira, P. C., Cohen, D. R., Edwards, S. A., Shows, T. B., Curran, T. et al. (1988) Azinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell (Cambridge, Mass.) 53, 37-43
44. Gineitis, D. and Treisman, R. (2001) Differential usage of signal transduction pathways defines two types of serum response factor target gene. J. Biol. Chem. 276, 24531-24539
45. Guerra, S., Lopez-Fernandez, L. A., Pascual-Montano, A., Munoz, M., Harshman, K. and Esteban, M. (2003) Cellular gene expression survey of vaccinia virus infection of human HeLa cells. J. Virol. 77, 6493-6506
46. Janknecht, R., Ernst, W. H., Pingoud, V. and Nordheim, A. (1993) Activation of ternary complex factor Elk-1 by MAP kinases. EMBO J. 12, 5097-5104
47. Davidson, L., Pawson, A. J., Millar, R. P. and Maudsley, S. (2004) Cytoskeletal reorganization dependence of signalling by the gonadotropin- releasing hormone receptor. J. Biol. Chem. 279, 1980-1993
48. Kawamura, S., Miyamoto, S. and Brown, J. H. (2003) Initiation and transduction of stretch-induced RhoA and Rac1 activation through caveolae: cytoskeletal regulation of ERK translocation. J. Biol. Chem. 278, 31111-31117
49. Ploubidou, A., Moreau, V., Ashman, K., Reckmann, I., Gonzalez, C. and Way, M. (2000) Vaccinia virus infection disrupts microtubule organization and centrosome function. EMBO J. 19, 3932-3944
50. Mallardo, M., Schleich, S. and Krijnse Locker, J. (2001) Microtubule-dependent organization of vaccinia virus core-derived early mRNAs into distinct cytoplasmic structures. Mol. Biol. Cell 12, 3875-3891
51. Giambartolomei, S., Covone, F., Levrero, M. and Balsano, C. (2001) Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C virus (HCV) core protein. Oncogene 20, 2606-2610